Edition:
India

People: Healios KK (4593.T)

4593.T on Tokyo Stock Exchange

1,234JPY
19 Nov 2019
Change (% chg)

¥-14 (-1.12%)
Prev Close
¥1,248
Open
¥1,248
Day's High
¥1,252
Day's Low
¥1,216
Volume
131,400
Avg. Vol
149,180
52-wk High
¥2,160
52-wk Low
¥1,116

Reaves, Al 

Mr. Al Reaves has been serving as Director of Global Development and Director in Healios K.K. since January 2014. He is also serving as President in OphthaConsult, LLC. He used to work for Alcon Laboratories, Inc., Xenon Vision, Inc., Novartis Ophthalmics, Neurotech USA, Inc., Othera Pharmaceuticals, Inc. and Acucela, Inc.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --